All Stories

  1. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing
  2. Diagnostics 4.0: the medical laboratory in digital health
  3. Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor Therapy
  4. Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)
  5. Thirteen Years of an International External Quality Assessment Scheme for Genotyping: Results and Recommendations
  6. Nuclear Death Receptor TRAIL-R2 Inhibits Maturation of Let-7 and Promotes Proliferation of Pancreatic and Other Tumor Cells